Taiwan FDA registration 334d8627ebf7b0e869bf6d42d94a0ccd
Sekisui Nanopia TDM Everolimus
TW: 積水鈉諾比亞依維莫司測定試劑
Taiwan·Risk Class 2·MD·SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT·Registered Jan 30, 2018 – Jan 30, 2028ActiveRegistration details
- Analysis ID
- 334d8627ebf7b0e869bf6d42d94a0ccd
- License Form
- Ministry of Health Medical Device Import No. 030494
- Customs Code
- DHA05603049409
Company information
- Manufacturer
- SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT
- Manufacturer Country
- Japan
- Authorized Representative
- KUO'S YUAN IN ENTERPRISE CO., LTD.
Product details
- Intended Use
- Used to measure the concentration of Everolimus in whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A3840 Sirolimus Drug Testing System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 30, 2018
- Expiry Date
- Jan 30, 2028
About this record
Access comprehensive regulatory information for Sekisui Nanopia TDM Everolimus in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 334d8627ebf7b0e869bf6d42d94a0ccd and manufactured by SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices